Paralogue | Variant | Associated Disease | Mapping Quality | Consensus | Pubmed |
---|---|---|---|---|---|
KCNB2 | E522K | Brugada syndrome | Low | 1 | 25339316 |
To assess whether the paralogue annotation here confidently predicts that variation at this residue is pathogenic, it is important to check the reports in the Pubmed links above to ascertain that the mutations in these paralogues have been proved likely to be disease-causing. It is also important to check that the direction of effect of the variant in the paralogue is compatible with your observed phenotype in KCNQ1.
KCNQ1 | ---------------TP-GEKMLTVPHITC>D<PPEERRL--------DHFSVDGYDSSVRKS | 468 |
KCNQ2 | ---------------AAKGKGSPQAQTVRR>S<PSADQSLED-SPSKVPKSW--SFGDRSRAR | 493 |
KCNQ3 | ---------------NTKGKL--------F>T<PLNVDAIEE-SPSKEPKPV--GLNNKERFR | 473 |
KCNQ4 | ---------------TGPSKQHLAPPTMPT>S<PSSEQVGEATSPTKVQKSW--SFNDRTRFR | 492 |
KCNQ5 | ---------------SIKSRQ--ASVGDRR>S<PSTDITAEG-SPTKVQKSW--SFNDRTRFR | 474 |
KCNA1 | ------------------------------>-<------------------------------ | |
KCNA10 | ------------------------------>-<------------------------------ | |
KCNA2 | ------------------------------>-<------------------------------ | |
KCNA3 | ------------------------------>-<------------------------------ | |
KCNA4 | ------------------------------>-<------------------------------ | |
KCNA5 | ------------------------------>-<------------------------------ | |
KCNA6 | ------------------------------>-<------------------------------ | |
KCNA7 | ------------------------------>-<------------------------------ | |
KCNB1 | ---------------SFETKEQGSPEK--->-<---ARSSSSPQH-----L------------ | 524 |
KCNB2 | ---------------SFENKYQEVSQKDSH>E<QLNNTSSSSPQH-----L------------ | 535 |
KCNC1 | ------------------------------>-<------------------------------ | |
KCNC2 | ------------------------------>-<------------------------------ | |
KCNC3 | ------------------------------>-<------------------------------ | |
KCNC4 | ------------------------------>-<------------------------------ | |
KCND1 | ---------------CHE------------>-<----F------------T------------ | 494 |
KCND2 | ---------------NHE------------>-<----F------------V------------ | 494 |
KCND3 | LVDDPLLSVRTSTIKNHE------------>-<----F------------I------------ | 511 |
KCNF1 | ------------------------------>-<------------------------------ | |
KCNG1 | ------------------------------>-<------------------------------ | |
KCNG2 | ------------------------------>-<------------------------------ | |
KCNG3 | ------------------------------>-<------------------------------ | |
KCNG4 | ------------------------------>-<------------------------------ | |
KCNS1 | ------------------------------>-<------------------------------ | |
KCNS2 | ------------------------------>-<------------------------------ | |
KCNS3 | ---------------ENCTA---------->-<------------------------------ | 490 |
KCNV1 | ------------------------------>-<------------------------------ | |
KCNV2 | ------------------------------>-<------------------------------ | |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.D446E | c.1338C>G | Inherited Arrhythmia | LQTS | rs199472780 | SIFT: tolerated Polyphen: benign |
Reports | Inherited Arrhythmia | LQTS | Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm. 2009 6(9):1297-303. 19716085 | ||
Inherited Arrhythmia | LQTS | Next generation sequencing for molecular confirmation of hereditary sudden cardiac death syndromes. Arch Cardiol Mex. 2015 85(1):68-72. doi: 10.1016/j.acmx.2014.12.006. 25661095 | |||
p.D446N | c.1336G>A | Putative Benign | rs149089817 | SIFT: deleterious Polyphen: possibly damaging |